Bayban’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bayban's LLY Position: Q3 2026 in Review
Bayban increased its Eli Lilly (LLY) stake by 5% in Q3 2026, buying an estimated $7.08K and bringing the position to 127 shares worth $147K. The position accounts for 0.11% of the portfolio, ranked #133.
Bayban first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $170K in Q4 2025. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Bayban held 127 shares of Eli Lilly worth $147K as of Q3 2026.
- Bayban bought 6 Eli Lilly shares in Q3 2026, an estimated $7.08K.
- Eli Lilly made up 0.11% of Bayban's portfolio in Q3 2026, its #133 holding.
- Bayban first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Bayban's Eli Lilly position peaked at $170K in Q4 2025.
- 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.